Published on in Vol 7 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49965, first published .
Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial

Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial

Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial

Isaac Weber   1 * , MD ;   Caterina Zagona-Prizio   2 * , BS ;   Torunn E Sivesind   2 * , MD ;   Madeline Adelman   2 * , MD ;   Mindy D Szeto   2 , MS ;   Ying Liu   3 , PhD ;   Stefan H Sillau   3 , PhD ;   Jacquelyn Bainbridge   3 , PharmD ;   Jost Klawitter   3 , PhD ;   Cristina Sempio   3 , PhD ;   Cory A Dunnick   2 , MD ;   Maureen A Leehey   3 , MD ;   Robert P Dellavalle   2, 4, 5 , MSPH, MD, PhD

1 Mercy Hopsital St. Louis, St. Louis, MO, United States

2 Department of Dermatology, University of Colorado School of Medicine, Aurora, CO, United States

3 Department of Neurology, University of Colorado School of Medicine, Aurora, CO, United States

4 Dermatology Service, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, United States

5 Colorado School of Public Health, Aurora, CO, United States

*these authors contributed equally

Corresponding Author:

  • Robert P Dellavalle, MSPH, MD, PhD
  • Dermatology Service
  • Rocky Mountain Regional Veterans Affairs Medical Center
  • 1700 N Wheeling St, Rm E1-342
  • Aurora, CO, 80045
  • United States
  • Phone: 1 720-857-5562
  • Email: Robert.dellavalle@ucdenver.edu